HMG-CoAȯ¿øÈ¿¼Ò¾ïÁ¦Á¦À¯¹ß±Ùº´Áõ¿¡ µ¿¹ÝµÈ ±Ù±äÀåÀüÀ§
Myotonic Potentials in the Myopathy Induced by HMG-CoA Reductase Inhibitor
´ëÇѽŰæ°úÇÐȸÁö 2014³â 32±Ç 3È£ p.186 ~ p.189
±èÀ²Èñ(Kim Yool-Hee) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±è°æ¿ì(Kim Kyoung-Woo) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¾È¼ÒÇö(Ahn So-Hyun) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¿À¹Ì¼±(Oh Mee-Sun) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¸¶È¿ÀÏ(Ma Hyeo-Il) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±èÀ±Áß(Kim Yun-Jung) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
À̺´Ã¶(Lee Byung-Chul) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
Abstract
HMG-CoA reductase inhibitor is widely used for the treatment of dyslipidemia, and for the prevention of stroke and cardiovascular disease. However, it is necessary to consider the adverse effects associated with this drug. Myopathy is a well-known side effect of statin therapy, but myotonic potentials in cases with statin myopathy have thus far been reported only rarely. We report four cases of myopathy with myotonic potentials on electromyography after multidrug administration. All of the patients recovered shortly after statin withdrawal.
Å°¿öµå
Myotonic potential, HMG-CoA reductase inhibitor, Myopathy
KMID :
0359720140320030186
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)